Search

everythinglearnresearchcommunity

for

Search:↓

MPA increases cancer spread by boosting Eph A2 activity.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

The MDhair app accurately assesses hair loss severity with 94% accuracy.

Blood metabolites significantly influence alopecia areata risk.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Combining stem cell medium and light therapy improves wound healing in diabetic rats.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Androgenetic alopecia patients have a higher risk of metabolic syndrome.

TA-Ado effectively promotes hair growth and reduces hair loss.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Insulin resistance is a complex condition that can lead to many diseases and has few treatment options.

Alefacept showed some effectiveness for alopecia areata but needs more research.

AP-1 controls tumor cell type by affecting key signaling pathways.